This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy
(opens in a new window).
| Department | Department of International Clinical Development |
|---|
Ms. Tomomi HATA has been working as a project manager of global investigator initiated directed clinical trials (IIRDTs).
She is a responsible PM of Asian investigator-initiated randomized phase III trial for hormone-receptor positive, HER2-negative metastatic breast cancer (PATHWAY trial, NCT03423199).
She is also involved in education for oncology clinical trials professionals based on her extensive experience in Clinical Research Coordinator, IRB administration staff, and academia Project Manager.
| 2020-Present | Head of International Professional Education Section, Department of International Clinical Development, National Cancer Center Hospital |
| 2018-Present | Head of International Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital |
| 2014-2018 | Staff Clinical Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital |
| 2010-2014 | Staff Kitasato Academic Research Organization, Kitasato University |
| 2007-2010 | Staff Research Management Department, Research Center, St. Luke’s International Hospital |
